These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26212323)

  • 21. Building a mechanistic mathematical model of hepatitis C virus entry.
    Kalemera M; Mincheva D; Grove J; Illingworth CJR
    PLoS Comput Biol; 2019 Mar; 15(3):e1006905. PubMed ID: 30883541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
    Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
    J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
    Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
    Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
    Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
    J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    Cheng JC; Yeh YJ; Pai LM; Chang ML; Yeh CT
    J Med Virol; 2009 Sep; 81(9):1560-8. PubMed ID: 19626614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
    J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear receptor 4 group A member 1 determines hepatitis C virus entry efficiency through the regulation of cellular receptor and apolipoprotein E expression.
    Zhu W; Pei R; Jin R; Hu X; Zhou Y; Wang Y; Wu C; Lu M; Chen X
    J Gen Virol; 2014 Jul; 95(Pt 7):1510-1521. PubMed ID: 24744301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
    Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
    Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
    Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
    J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
    Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
    Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for CD81 and hepatitis C virus in hepatoma mobility.
    Brimacombe CL; Wilson GK; Hübscher SG; McKeating JA; Farquhar MJ
    Viruses; 2014 Mar; 6(3):1454-72. PubMed ID: 24662676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.
    Qian XJ; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Wang Y; Zhao P; Qi ZT; Zhu YZ
    J Gen Virol; 2016 May; 97(5):1134-1144. PubMed ID: 26879209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
    McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
    J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.
    Wu X; Lee EM; Hammack C; Robotham JM; Basu M; Lang J; Brinton MA; Tang H
    J Virol; 2014 Aug; 88(15):8433-44. PubMed ID: 24829338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
    Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
    Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines.
    Sasaki M; Yamauchi K; Nakanishi T; Kamogawa Y; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):74-9. PubMed ID: 12519228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.